Drawing for RX DIRECT

USPTO serial 75436751

RX DIRECT

Reviewed by CopyMark Law Group

Status 603
Filing date
Status date
Registration date
Examiner
JENKINS JR, CHARLES L
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with RX DIRECT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
035For promoting the sale of prescription drugs of others through the distribution of messages, magazines and/or Direct Mail Advertisements based on consumer purchaser behaviorACTIVENov 18, 1997

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 29, 2000ABN3ABANDONMENT - AFTER EX PARTE APPEAL
Aug 1, 2000EXPTEXPARTE APPEAL TERMINATED
Mar 28, 2000EXFBEXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF
Jan 4, 2000EXPIEX PARTE APPEAL-INSTITUTED
Jun 23, 1999CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 23, 1998CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 5, 1998DOCKASSIGNED TO EXAMINER
Sep 29, 1998DOCKASSIGNED TO EXAMINER
Sep 29, 1998DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance